Differential inhibition of thromboxane B2 and leukotriene B4 biosynthesis by two naturally occurring acetylenic fatty acids.
The seed oil of the plant Ixiolaena brevicompta is a rich source of crepenynic acid (octadec-cis-9-en-12-ynoic acid), which has been linked with extensive sheep mortalities in Western New South Wales and Queensland, Australia. A number of acetylenic fatty acids have been found to interfere with lipid and fatty acid metabolism and inhibit cyclooxygenase and lipoxygenase enzymes in a variety of tissues. We have investigated the effects of crepenynic acid and ximenynic acid (octadec-trans-11-en-9-ynoic acid) on leukotriene B4 and thromboxane B2 production in rat peritoneal leukocytes and compare them with non-acetylenic compounds linoleic and ricinoleic acids. In concentrations ranging from 10 to 100 microM linoleic acid and ricinoleic acid had only minimal effects on leukotriene B4 and thromboxane B2 production in ionophore-stimulated cells. Ximenynic acid gave dose-dependent inhibition of leukotriene B4, thromboxane B2 and 6-ketoprostaglandin F1 alpha production. Ximenynic acid appears to be a more effective inhibitor of leukotriene B4 than crepenynic acid with an IC50 of 60 microM compared to 85 microM. On the other hand, crepenynic acid is a much more effective inhibitor of the cyclooxygenase products, having an IC50 for thromboxane B2 of less than 10 microM. Both acetylenic fatty acids inhibited phospholipase activity in these cells by 40-50% at a concentration of 100 microM but had no inhibitory effect at 10 microM. These results indicate that crepenynic acid and ximenynic acid differentially inhibit the cyclooxygenase and lipoxygenase products of stimulated leukocytes, and that at high doses of these fatty acids the effect on these products may be partially due to inhibition of phospholipase A2.
Croft
K D
KD
Department of Medicine, University of Western Australia, Royal Perth Hospital.
Beilin
L J
LJ
Ford
G L
GL
D000480:Alkynes; D000818:Animals; D016861:Cyclooxygenase Inhibitors; D007962:Leukocytes / Q000378:metabolism; D007975:Leukotriene B4 / Q000096:biosynthesis*; D019787:Linoleic Acid; D008041:Linoleic Acids / Q000494:pharmacology; D016859:Lipoxygenase Inhibitors; D009829:Oleic Acids / Q000494:pharmacology*; D010529:Peritoneal Cavity / Q000166:cytology; D010740:Phospholipases / Q000037:antagonists & inhibitors; D051381:Rats; D012277:Ricinoleic Acids / Q000494:pharmacology; D013929:Thromboxane B2 / Q000096:biosynthesis*
D000480:Alkynes; D016861:Cyclooxygenase Inhibitors; D008041:Linoleic Acids; D016859:Lipoxygenase Inhibitors; D009829:Oleic Acids; D012277:Ricinoleic Acids; C047148:crepenynic acid; D007975:Leukotriene B4; D013929:Thromboxane B2; D019787:Linoleic Acid; D010740:Phospholipases; C030521:ricinoleic acid; C053760:ximenynic acid